We are thrilled to announce that Dr. Shlomo Sadoun, Co-Founder and CEO of SK Pharma Group, has been appointed as an Honorary Global Advisory Board Member at Etherea Global University, USA.
This prestigious appointment is a testament to Dr. Sadoun’s remarkable expertise and visionary leadership in the pharmaceutical industry. His insights and guidance will undoubtedly inspire and enrich the global academic community at Etherea Global University.
Dr. Sadoun’s involvement with Etherea Global University is a monumental step in fostering innovation, excellence, and transformative education. His contributions will drive forward our collective efforts to make a lasting impact in academia and beyond.
Related Articles Leadership
June 25, 2026
Complex Generics Commercialization Support
February 25, 2026
The Silent Shift in Pharma: From Volume to Value
September 22, 2025
Choosing Humanity: A New Year’s Wish for Pharma Leadership
Contact Us
Our regulatory specialists will be pleased to support you throughout the entire Section 29 import process.
Related Articles
July 14, 2024
The Role of Data-Driven Solutions in Modern Healthcare
April 10, 2025
The ESG Reckoning in Pharma: Real Sustainability or Just PR?
September 11, 2024
Facing the Fear: Understanding Employee Resistance to Organizational Change
Contact Us
Our regulatory specialists will be pleased to support you throughout the entire Section 29 import process.